After FDR correction, neurocan core proteins (CSPG3), cartilage intermediate layer protein 2 (CILP2), Apolipoprotein E (Apo-E), and glucokinase regulatory protein (GCKR) were found to be associated with NAFLD (PFDR < 0.05). The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.